BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 12564291)

  • 1. [Diabetic encephalopathy: an underexposed complication of diabetes mellitus].
    Brands AM; Henselmans JM; de Haan EH; Biessels GJ
    Ned Tijdschr Geneeskd; 2003 Jan; 147(1):11-4. PubMed ID: 12564291
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cerebral dysfunction in type 1 diabetes: effects of insulin, vascular risk factors and blood-glucose levels.
    Brands AM; Kessels RP; de Haan EH; Kappelle LJ; Biessels GJ
    Eur J Pharmacol; 2004 Apr; 490(1-3):159-68. PubMed ID: 15094082
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Autonomic neuropathy in diabetic patients. Part I. Pathogenesis and clinical problems].
    Otto-Buczkowska E; Chobot PJ
    Pol Merkur Lekarski; 2002 Aug; 13(74):158-60. PubMed ID: 12420352
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulin, C-peptide, hyperglycemia, and central nervous system complications in diabetes.
    Sima AA; Kamiya H; Li ZG
    Eur J Pharmacol; 2004 Apr; 490(1-3):187-97. PubMed ID: 15094085
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diabetic nephropathy--are there differences between type I and type II?
    Ritz E; Hasslacher C; Tschöpe W
    Miner Electrolyte Metab; 1990; 16(1):69-72. PubMed ID: 2182996
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuropathology of diabetic neuropathy and its correlations with neurophysiology.
    Sima AA; Cherian PV
    Clin Neurosci; 1997; 4(6):359-64. PubMed ID: 9358980
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Neurologic manifestations of diabetes mellitus: an overview].
    Berek K; Luef G; Grubwieser G; Aichner F
    Wien Klin Wochenschr; 1994; 106(5):128-35. PubMed ID: 8171868
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The effect of sermion on brain function in diabetics].
    Efimov AS; Man'kovskiĭ BN
    Vrach Delo; 1991 Nov; (11):73-6. PubMed ID: 1801441
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Encephalopathies: the emerging diabetic complications.
    Sima AA
    Acta Diabetol; 2010 Dec; 47(4):279-93. PubMed ID: 20798963
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peripheral and central neurologic complications in type 2 diabetes mellitus: no association in individual patients.
    Manschot SM; Biessels GJ; Rutten GE; Kessels RP; Gispen WH; Kappelle LJ;
    J Neurol Sci; 2008 Jan; 264(1-2):157-62. PubMed ID: 17850822
    [TBL] [Abstract][Full Text] [Related]  

  • 11. From heart to sole. Diabetes and the heart-foot connection.
    Gottlieb SH
    Diabetes Forecast; 2002 Sep; 55(9):37-9. PubMed ID: 14765461
    [No Abstract]   [Full Text] [Related]  

  • 12. Diabetic neuropathy differs in type 1 and type 2 diabetes.
    Sima AA; Kamiya H
    Ann N Y Acad Sci; 2006 Nov; 1084():235-49. PubMed ID: 17151305
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Autonomic neuropathy in diabetic patients. Part II. Diagnosis and treatment].
    Otto-Buczkowska E; Chobot PJ
    Pol Merkur Lekarski; 2002 Aug; 13(74):161-4. PubMed ID: 12420353
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Type 1 diabetic neuropathy and C-peptide.
    Sima AA; Zhang W; Grunberger G
    Exp Diabesity Res; 2004; 5(1):65-77. PubMed ID: 15198372
    [TBL] [Abstract][Full Text] [Related]  

  • 15. C-peptide and central nervous system complications in diabetes.
    Li ZG; Sima AA
    Exp Diabesity Res; 2004; 5(1):79-90. PubMed ID: 15198373
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between peripheral diabetic neuropathy and microvascular reactivity in patients with type 1 and type 2 diabetes mellitus -- neuropathy and microcirculation in diabetes.
    Kasalová Z; Prázný M; Skrha J
    Exp Clin Endocrinol Diabetes; 2006 Feb; 114(2):52-7. PubMed ID: 16570233
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurophysiological role of sildenafil citrate (Viagra) on seminal parameters in diabetic males with and without neuropathy.
    Ali ST; Rakkah NI
    Pak J Pharm Sci; 2007 Jan; 20(1):36-42. PubMed ID: 17337426
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Type 2 diabetes, cognitive function and dementia: vascular and metabolic determinants.
    van den Berg E; Kessels RP; Kappelle LJ; de Haan EH; Biessels GJ;
    Timely Top Med Cardiovasc Dis; 2007 Feb; 11():E7. PubMed ID: 17380217
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early vascular risk factor modification in type 1 diabetes.
    Perkins BA; Bril V
    N Engl J Med; 2005 Jan; 352(4):408-9. PubMed ID: 15673807
    [No Abstract]   [Full Text] [Related]  

  • 20. [The role of the system of hemostasis in the development of vascular lesions in diabetes mellitus].
    Lapotnikov VA; Moiseev SI
    Ter Arkh; 1988; 60(9):31-5. PubMed ID: 3217876
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.